132 related articles for article (PubMed ID: 29523166)
1. Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys.
Nguyen QN; Martinez DR; Himes JE; Whitney Edwards R; Han Q; Kumar A; Mangan R; Nicely NI; Xie G; Vandergrift N; Shen X; Pollara J; Permar SR
Retrovirology; 2018 Mar; 15(1):24. PubMed ID: 29523166
[TBL] [Abstract][Full Text] [Related]
2. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.
Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M
J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162
[TBL] [Abstract][Full Text] [Related]
3. Effect of B-cell depletion on viral replication and clinical outcome of simian immunodeficiency virus infection in a natural host.
Gaufin T; Pattison M; Gautam R; Stoulig C; Dufour J; MacFarland J; Mandell D; Tatum C; Marx MH; Ribeiro RM; Montefiori D; Apetrei C; Pandrea I
J Virol; 2009 Oct; 83(20):10347-57. PubMed ID: 19656874
[TBL] [Abstract][Full Text] [Related]
4. A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies.
Bibollet-Ruche F; Russell RM; Ding W; Liu W; Li Y; Wagh K; Wrapp D; Habib R; Skelly AN; Roark RS; Sherrill-Mix S; Wang S; Rando J; Lindemuth E; Cruickshank K; Park Y; Baum R; Carey JW; Connell AJ; Li H; Giorgi EE; Song GS; Ding S; Finzi A; Newman A; Hernandez GE; Machiele E; Cain DW; Mansouri K; Lewis MG; Montefiori DC; Wiehe KJ; Alam SM; Teng IT; Kwong PD; Andrabi R; Verkoczy L; Burton DR; Korber BT; Saunders KO; Haynes BF; Edwards RJ; Shaw GM; Hahn BH
mBio; 2023 Feb; 14(1):e0337022. PubMed ID: 36629414
[TBL] [Abstract][Full Text] [Related]
5. High major histocompatibility complex-unrestricted lysis of simian immunodeficiency virus envelope-expressing cells predisposes macaques to rapid AIDS progression.
Yin C; Wu MS; Pauza CD; Salvato MS
J Virol; 1999 May; 73(5):3692-701. PubMed ID: 10196261
[TBL] [Abstract][Full Text] [Related]
6. Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes.
Nelson AN; Goswami R; Dennis M; Tu J; Mangan RJ; Saha PT; Cain DW; Curtis AD; Shen X; Shaw GM; Bar K; Hudgens M; Pollara J; De Paris K; Van Rompay KKA; Permar SR
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092583
[TBL] [Abstract][Full Text] [Related]
7. African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity.
Raehtz KD; Barrenäs F; Xu C; Busman-Sahay K; Valentine A; Law L; Ma D; Policicchio BB; Wijewardana V; Brocca-Cofano E; Trichel A; Gale M; Keele BF; Estes JD; Apetrei C; Pandrea I
PLoS Pathog; 2020 Mar; 16(3):e1008333. PubMed ID: 32119719
[TBL] [Abstract][Full Text] [Related]
8. Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein.
Grunst MW; Ladd RA; Clark NM; Gil HM; Klenchin VA; Mason R; Franchini G; Roederer M; Evans DT
PLoS Pathog; 2023 May; 19(5):e1011407. PubMed ID: 37253062
[TBL] [Abstract][Full Text] [Related]
9. SIVagm infection in wild African green monkeys from South Africa: epidemiology, natural history, and evolutionary considerations.
Ma D; Jasinska A; Kristoff J; Grobler JP; Turner T; Jung Y; Schmitt C; Raehtz K; Feyertag F; Martinez Sosa N; Wijewardana V; Burke DS; Robertson DL; Tracy R; Pandrea I; Freimer N; Apetrei C;
PLoS Pathog; 2013 Jan; 9(1):e1003011. PubMed ID: 23349627
[TBL] [Abstract][Full Text] [Related]
10. Dynamic evolution of antibody populations in a rhesus macaque infected with attenuated simian immunodeficiency virus identified by surface plasmon resonance.
Steckbeck JD; Grieser HJ; Sturgeon T; Taber R; Chow A; Bruno J; Murphy-Corb M; Montelaro RC; Cole KS
J Med Primatol; 2006 Aug; 35(4-5):248-60. PubMed ID: 16872288
[TBL] [Abstract][Full Text] [Related]
11. High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.
Pollara J; Hart L; Brewer F; Pickeral J; Packard BZ; Hoxie JA; Komoriya A; Ochsenbauer C; Kappes JC; Roederer M; Huang Y; Weinhold KJ; Tomaras GD; Haynes BF; Montefiori DC; Ferrari G
Cytometry A; 2011 Aug; 79(8):603-12. PubMed ID: 21735545
[TBL] [Abstract][Full Text] [Related]
12. Prolonged experimental CD4
Le Hingrat Q; Sette P; Xu C; Rahmberg AR; Tarnus L; Annapureddy H; Kleinman A; Brocca-Cofano E; Sivanandham R; Sivanandham S; He T; Capreri DJ; Ma D; Estes JD; Brenchley JM; Apetrei C; Pandrea I
Nat Commun; 2023 Feb; 14(1):979. PubMed ID: 36813761
[TBL] [Abstract][Full Text] [Related]
13. Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies.
Kuriakose Gift S; Wieczorek L; Sanders-Buell E; Zemil M; Molnar S; Donofrio G; Townsley S; Chenine AL; Bose M; Trinh HV; Barrows BM; Sriplienchan S; Kitsiripornchai S; Nitayapan S; Eller LA; Rao M; Ferrari G; Michael NL; Ake JA; Krebs SJ; Robb ML; Tovanabutra S; Polonis VR
J Virol; 2023 Feb; 97(2):e0163522. PubMed ID: 36749076
[TBL] [Abstract][Full Text] [Related]
14. Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function.
Curriu M; Fausther-Bovendo H; Pernas M; Massanella M; Carrillo J; Cabrera C; López-Galíndez C; Clotet B; Debré P; Vieillard V; Blanco J
PLoS One; 2012; 7(2):e30330. PubMed ID: 22312424
[TBL] [Abstract][Full Text] [Related]
15. Antiviral antibodies are necessary for control of simian immunodeficiency virus replication.
Miller CJ; Genescà M; Abel K; Montefiori D; Forthal D; Bost K; Li J; Favre D; McCune JM
J Virol; 2007 May; 81(10):5024-35. PubMed ID: 17329327
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Envelope Glycoproteins Proteolytic Cleavage Protects Infected Cells from ADCC Mediated by Plasma from Infected Individuals.
Prévost J; Medjahed H; Vézina D; Chen HC; Hahn BH; Smith AB; Finzi A
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835042
[TBL] [Abstract][Full Text] [Related]
17. Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses.
Eastman D; Piantadosi A; Wu X; Forthal DN; Landucci G; Kimata JT; Overbaugh J
Virol J; 2008 Aug; 5():90. PubMed ID: 18680596
[TBL] [Abstract][Full Text] [Related]
18. Elimination of SHIV Infected Cells by Combinations of Bispecific HIVxCD3 DART
Tuyishime M; Dashti A; Faircloth K; Jha S; Nordstrom JL; Haynes BF; Silvestri G; Chahroudi A; Margolis DM; Ferrari G
Front Immunol; 2021; 12():710273. PubMed ID: 34484212
[TBL] [Abstract][Full Text] [Related]
19. Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1.
Nelson AN; Dennis M; Mangold JF; Li K; Saha PT; Cronin K; Cross KA; Kumar A; Mangan RJ; Shaw GM; Bar KJ; Haynes B; Moody AM; Munir Alam S; Pollara J; Hudgens MG; Van Rompay KKA; De Paris K; Permar SR
NPJ Vaccines; 2022 Jul; 7(1):87. PubMed ID: 35907918
[TBL] [Abstract][Full Text] [Related]
20. Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains.
Steckbeck JD; Orlov I; Chow A; Grieser H; Miller K; Bruno J; Robinson JE; Montelaro RC; Cole KS
J Virol; 2005 Oct; 79(19):12311-20. PubMed ID: 16160158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
